1. bis(2,6-dioxopiperaxine) derivatives, topoisomerase II inhibitors which do not form a DNA cleavable complex, induce thymocyte apoptosis.
- Author
-
Onishi Y, Azuma Y, and Kizaki H
- Subjects
- Animals, Antineoplastic Agents pharmacology, Cells, Cultured, Cycloheximide pharmacology, Dactinomycin pharmacology, Dose-Response Relationship, Drug, Etoposide toxicity, Gene Expression Regulation drug effects, Male, Mice, Mice, Inbred BALB C, Nucleic Acid Conformation drug effects, Razoxane pharmacology, Thymus Gland cytology, Thymus Gland drug effects, Apoptosis drug effects, DNA Damage drug effects, Piperazines pharmacology, Razoxane analogs & derivatives, Topoisomerase I Inhibitors
- Abstract
Internucleosomal DNA fragmentation and cell death were induced dose- and time-dependently by incubation of mouse thymocytes with bis(2,6-dioxopiperazine) derivatives, ICRF-154 and MST-16, inhibitors of topoisomerase II, which do not induce cleavable complex formation. The process was inhibited by actinomycin D and cycloheximide, indicating that the process was an active apoptotic process. Bis(2,6-dioxopiperazine) derivatives have been known to inhibit the etoposide-induced DNA cleavage, but ICRF-154 did not inhibit etoposide-induced apoptosis in thymocytes at 6 h incubation, suggesting that DNA cleavage is not essential for induction of apoptosis by topoisomerase II inhibitors. The alteration of DNA helicity induced by a subtle inhibition of topoisomerase II activity may have an important role in the induction of apoptosis in thymocytes, since topoisomerase II is a major component of the nuclear matrix that can regulate gene expression.
- Published
- 1994